Aik Pipes & Poly (544072)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE is positive at 8.62%, suggesting some operating return on existing capital despite recent losses.
• Small market cap of ₹87 Cr means a genuine operational recovery could have a meaningful percentage impact.
• The stock has attracted significant market attention, moving from ₹19.02 to ₹135, which provides trading liquidity and visibility if the company delivers a real turnaround.

Concerns

• Sales growth is down 88.09% and profit growth has fallen 162.50%, indicating a severe business collapse.
• Latest quarter is deeply loss-making: ₹2 Cr sales with a ₹1 Cr net loss, implying negative net margins of roughly 50%.
• Piotroski F-Score of 3/9 indicates weak financial health and poor balance-sheet signals.
• Valuation appears disconnected from fundamentals: ₹87 Cr market cap against quarterly sales of just ₹2 Cr, with zero dividend and no current earnings.

AI Analysis

Price is what you pay; value is what you get. For Aik Pipes & Poly, the price has moved from ₹19.02 to ₹135 in the 52-week range, yet the underlying business has collapsed. Sales are down 88.09% and profit growth is negative 162.50%. The latest quarter shows ₹2 Cr of sales and a net loss of ₹1 Cr — that is a 50% loss on every rupee of revenue. A P/E of 0.00 is not a cheap multiple; it is an absence of earnings. With no book value, no ROE, no debt-to-equity, and no promoter holding data, I cannot even apply Graham's basic tests. The Piotroski F-score of 3/9 reinforces my caution: this is a financially weak picture. ROCE of 8.62% is positive, but it is far too thin for a business with such negative momentum, and it tells me nothing about earnings power. Plastic products in the industrial space rarely have wide moats unless they hold a unique cost or technology advantage; nothing in these numbers suggests one exists. Could this be a turnaround? Possibly. The market cap is only ₹87 Cr, so small absolute improvements could produce large percentage gains. But the stock has already risen over 600% from its low, pricing in a recovery that has not yet appeared in the financials. Buffett and Graham would say: do not pay for hope; wait for evidence. A sales stabilisation, a narrowing loss, or a visible path to profitability would change my view. Today, this is a speculation, not an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer